TrademarkDir
ARCHIMMUNE
DEAD

Serial Number

97276905

Owner

Archimmune Therapeutics Inc.

Attorney

Perry Gattegno

Filing Date

Feb 21, 2022

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ARCHIMMUNE Trademark

Serial Number: 97276905

ARCHIMMUNE is a trademark filed by Archimmune Therapeutics Inc. on February 21, 2022. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Archimmune Therapeutics Inc. (2 trademarks)

91 Hartwell Avenue
Lexington, MA 02421

Entity Type: 03

Trademark Details

Filing Date

February 21, 2022

Registration Date

Not Registered

Published for Opposition

January 10, 2023

Goods & Services

Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Biochemical research and development; Consulting services in the field of pharmacogenetics; Pharmaceutical research and development; Scientific research and development; Vaccine research and development

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Apr 13, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Apr 13, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 27, 2025 EXRA
SOU EXTENSION 5 GRANTED
Aug 27, 2025 EX5G
SOU TEAS EXTENSION RECEIVED
Aug 18, 2025 EEXT
SOU EXTENSION 5 FILED
Aug 17, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 25, 2025 EXRA
SOU EXTENSION 4 GRANTED
Feb 25, 2025 EX4G
SOU EXTENSION 4 FILED
Feb 24, 2025 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 24, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 27, 2024 EXRA
SOU EXTENSION 3 GRANTED
Aug 27, 2024 EX3G
SOU EXTENSION 3 FILED
Aug 27, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Aug 27, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 7, 2024 EXRA
SOU EXTENSION 2 GRANTED
Feb 5, 2024 EX2G
SOU EXTENSION 2 FILED
Feb 5, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 5, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 27, 2023 EXRA
SOU EXTENSION 1 GRANTED
Oct 26, 2023 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 23, 2023 AITU
NOTICE OF REVIVAL - E-MAILED
Oct 11, 2023 NREV
SOU EXTENSION RECEIVED WITH TEAS PETITION
Oct 10, 2023 TPEX
NOTICE OF REVIVAL - E-MAILED
Oct 10, 2023 NREV
PETITION TO REVIVE-GRANTED
Oct 10, 2023 PETG
TEAS PETITION TO REVIVE RECEIVED
Oct 10, 2023 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 10, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 9, 2023 ABN6
SOU EXTENSION 1 FILED
Sep 7, 2023 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Mar 7, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 10, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jan 10, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 21, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 5, 2022 CNSA
ASSIGNED TO EXAMINER
Dec 5, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 24, 2022 NWOS
NEW APPLICATION ENTERED
Feb 24, 2022 NWAP

Related Trademarks

More from this Owner

ARCHIMMUNE ARCHITECTING IMMUNO-ONCOLOGY SOLUTIONS logo

ARCHIMMUNE ARCHITECTING IMMUNO-ONCOLOGY SOLUTIONS

ARCHIMMUNE ARCHITECTING IMMUNO-ONCOLOGY SOLUTIONS logo

ARCHIMMUNE ARCHITECTING IMMUNO-ONCOLOGY SOLUTIONS